One of the primary options for patient assistance is the Novo Nordisk Patient Assistance Program, offered by the manufacturer of Ozempic ... call a number or fill a form on our site.

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

Novo Nordisk’s Ozempic (semaglutide ... The decision makes Ozempic the only glucagon-like peptide-1 (GLP-1) receptor agonist approved for this patient population and the “most broadly indicated” drug ...